Astaxanthin inhibits thrombosis in cerebral vessels of stroke-prone spontaneously hypertensive rats

Nutrition Research

Volumn 31, Issue 10, 2011, Pages 784-789

  Sasaki, Yasuto ^a   Kobara, Nozomi ^a   Higashino, Saori ^a   Giddings, John C ^b   Yamamoto, Junichiro ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antioxidant; Astaxanthin; Nitric oxide; SHRSP rat; Thrombosis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ASTAXANTHIN; HELIUM; NEON; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD VESSEL; CEREBRAL SINUS THROMBOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; ESSENTIAL HYPERTENSION; MALE; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; THROMBOGENESIS; URINE LEVEL; WEIGHT GAIN;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HYPERTENSION; INTRACRANIAL THROMBOSIS; MALE; NITRATES; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RISK FACTORS; SPECIFIC PATHOGEN-FREE ORGANISMS; STROKE; XANTHOPHYLLS;

ANIMALIA; CRUSTACEA; RATTUS; SALMONIDAE;

EID: 80755171213     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.09.010     Document Type: Article

References (38)

1. Hsieh Y.S., Kuo W.H., Lin T.W., Chang H.R., Lin T.H., Chen P.N., et al. Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells. J Agric Food Chem 2007, 55:10437-10445.
2. Pashkow F.J., Watumull D.G., Campbell C.L. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol 2008, 101:58D-68D.
3. Traupe T., Ortmann J., Munter K., Barton M. Endothelial therapy of atherosclerosis and its risk factors. Curr Vasc Pharmacol 2003, 1:111-121.
4. Krotz F., Sohn H.Y., Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 2004, 24:1988-1996.
5. Minuz P., Patrignani P., Gaino S., Seta F., Capone M.L., Tacconelli S., et al. Determinants of platelet activation in human essential hypertension. Hypertension 2004, 43:64-70.
6. Clutton P., Miermont A., Freedman J.E. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation. Arterioscler Thromb Vasc Biol 2004, 24:187-192.
7. Freedman J.E. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 2008, 28:s11-s16.
8. Riccioni G. Carotenoids and cardiovascular disease. Curr Atheroscler Rep 2009, 11:434-439.
9. Lauver D.A., Driscoll E.M., Lucchesi B.R. Disodium disuccinate astaxanthin prevents carotid artery rethrombosis and ex vivo platelet activation. Pharmacology 2008, 82:67-73.
10. Naguib Y.M. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000, 48:1150-1154.
11. Fassett R.G., Healy H., Driver R., Robertson I.K., Geraghty D.P., Sharman J.E., et al. Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial. BMC Nephrol 2008, 9:17.
12. Yasui Y., Hosokawa M., Mikami N., Miyashita K., Tanaka T. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem Biol Interact 2011, 193:79-87.
13. Nakao R., Nelson O.L., Park J.S., Mathison B.D., Thompson P.A., Chew B.P. Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. Anticancer Res 2010, 30:2721-2725.
14. Negishi H., Ikeda K., Sagara M., Sawamura M., Yamori Y. Increased oxidative DNA damage in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1999, 26:482-484.
15. Noguchi T., Sasaki Y., Seki J., Giddings J.C., Yamamoto J. Enhanced thrombogenicity and altered hemodynamics in the cerebral microvasculature of stroke-prone spontaneously hypertensive rats. Haemostasis 1997, 27:237-245.
16. Guiding principles for the care and use of animals in the field of physiological sciences Japan Physiological Society. http://wwwsoc.nii.ac.jp/psj/psj/doubutu.html.
17. Morii S., Ngai A.C., Winn H.R. Reactivity of rat pial arterioles and venules to adenosine and carbon dioxide: with detailed description of the closed cranial window technique in rats. J Cereb Blood Flow Metab 1986, 6:34-41.
18. Sasaki Y., Noguchi T., Seki J., Giddings J.C., Yamamoto J. Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats. Thromb Haemost 2000, 83:722-727.
19. Sasaki Y., Noguchi T., Yamamoto E., Giddings J.C., Ikeda K., Yamori Y., et al. Effects of Ginkgo biloba extract (EGb 761) on cerebral thrombosis and blood pressure in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2002, 29:963-967.
20. Wu T.H., Liao J.H., Hou W.C., Huang F.Y., Maher T.J., Hu C.C. Astaxanthin protects against oxidative stress and calcium-induced porcine lens protein degradation. J Agric Food Chem 2006, 54:2418-2423.
21. Gross G.J., Hazen S.L., Lockwood S.F. Seven day oral supplementation with Cardax (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats. Mol Cell Biochem 2006, 283:23-30.
22. Palozza P., Barone E., Mancuso C., Picci N. The protective role of carotenoids against 7-keto-cholesterol formation in solution. Mol Cell Biochem 2008, 309:61-68.
23. Yoshida H., Yanai H., Ito K., Tomono Y., Koikeda T., Tsukahara H., et al. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 2010, 209:520-523.
24. Hussein G., Nakamura M., Zhao Q., Iguchi T., Goto H., Sankawa U., et al. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol Pharm Bull 2005, 28:47-52.
25. Umemoto S., Tanaka M., Kawahara S., Kubo M., Umeji K., Hashimoto R., et al. Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004, 27:877-885.
26. Tanaka M., Umemoto S., Kawahara S., Kubo M., Itoh S., Umeji K., et al. type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 2005, 28:67-77.
27. Nakamura T., Yamamoto E., Kataoka K., Yamashita T., Tokutomi Y., Dong Y.F., et al. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Hypertension 2008, 51:296-301.
28. Yamamoto E., Tamamaki N., Nakamura T., Kataoka K., Tokutomi Y., Dong Y.F., et al. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 2008, 39:3049-3056.
29. El Haouari M., Rosado J.A. Platelet function in hypertension. Blood Cells Mol Dis 2009, 42:38-43.
30. Rodrigo R., Gonzalez J., Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res 2011, 34:431-440.
31. Touyz R.M., Briones A.M. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res 2011, 34:5-14.
32. Kim Y.J., Kim Y.A., Yokozawa T. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J Agric Food Chem 2009, 57:8793-8797.
33. Khan S.K., Malinski T., Mason R.P., Kubant R., Jacob R.F., Fujioka K., et al. Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. Thromb Res 2010, 126:299-305.
34. Seno T., Inoue N., Gao D., Okuda M., Sumi Y., Matsui K., et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 2001, 103:399-409.
35. Wachowicz B., Olas B., Zbikowska H.M., Buczynski A. Generation of reactive oxygen species in blood platelets. Platelets 2002, 13:175-182.
36. Serbinova E.A., Packer L. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Methods Enzymol 1994, 234:354-366.
37. Mehta J., Li D., Mehta J.L. Vitamins C and E prolong time to arterial thrombosis in rats. J Nutr 1999, 129:109-112.
38. Krinsky N.I. Antioxidant functions of carotenoids. Free Radic Biol Med 1989, 7:617-635.